User:Mr. Ibrahem/Salmeterol
Clinical data | |
---|---|
Trade names | Serevent, Aeromax, others |
Other names | Salmeterol xinafoate |
AHFS/Drugs.com | Monograph |
License data |
|
Pregnancy category |
|
Routes of administration | Respiratory inhalation (Metered-dose inhaler (MDI), Dry-powder inhaler (DPI)) |
Drug class | Long-acting β2 adrenergic receptor agonist (LABA)[1] |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Protein binding | 96% |
Metabolism | Liver (CYP3A4) |
Onset of action | About 30 min[1] |
Elimination half-life | 5.5 hours |
Duration of action | 12 hr[3] |
Identifiers | |
| |
Chemical and physical data | |
Formula | C25H37NO4 |
Molar mass | 415.574 g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
| |
| |
(what is this?) (verify) |
Salmeterol, sold under the brand name Serevent among others, is a medication used in the maintenance of asthma or chronic obstructive pulmonary disease (COPD).[1] In asthma it is used together with a inhaled corticosteroid.[1] It is also used for exercise-induced bronchoconstriction.[1] Effects may begin in about 30 min and last about 12 hours.[1][3]
Common side effects include headache, runny nose, thrush, cough, and change in voice.[1] Other side effects may include low potassium, anaphylaxis, bronchospasm, and QT prolongation.[1] Use during pregnancy or breastfeeding is deemed reasonable.[3] It is a long-acting β2 adrenergic receptor agonist (LABA).[1]
Salmeterol was patented in 1983 and came into medical use in 1990.[4] In the United Kingdom 120 doses costs the NHS about £30 in 2021.[3] This amount in the United States costs about 800 USD.[5] It is also avaliable as fluticasone/salmeterol.[3]
References[edit]
- ^ a b c d e f g h i j k "Salmeterol". American Society of Health-System Pharmacists. Archived from the original on 25 July 2021. Retrieved 10 October 2021.
- ^ "Serevent Diskus- salmeterol xinafoate powder, metered". DailyMed. 13 January 2020. Archived from the original on 14 December 2020. Retrieved 6 September 2020.
- ^ a b c d e BNF (80 ed.). BMJ Group and the Pharmaceutical Press. September 2020 – March 2021. p. 266. ISBN 978-0-85711-369-6.
{{cite book}}
: CS1 maint: date format (link) - ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 543. ISBN 9783527607495. Archived from the original on 2021-07-24. Retrieved 2021-06-21.
- ^ "Salmeterol Xinafoate Prices, Coupons & Savings Tips - GoodRx". GoodRx. Retrieved 10 October 2021.